Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Population Health Insights on Closing Healthcare Gaps to Improve Health Equity with Kim Brunisholz Johnson & Johnson TRANSCRIPT
Download PDFJan 29, 2025
Kim Brunisholz, director of Population Health Research at Johnson & Johnson, is conducting research to bridge the gap between evidence-based care and its implementation in routine clinical practice. Overcoming the challenges of translating research into practice requires understanding patient-provider perspectives and using qualitative and quantitative methods to identify and address care gaps. This research can also identify root causes and barriers to care, enabling stakeholders to develop and implement interventions to improve patient care.
Kim explains, "My goal is really around how I impact the translation and implementation of evidence-based care into routine practice. What I'm looking to do is ensure that all patients have access to what we know works in medicine. So, there are a variety of questions that we may pursue in our research programs, mostly around how we might think around closing the evidence-to-practice gap for patients and bringing what we know works to them."
"It starts with the patient-provider relationship. And it's probably a lot harder than the public realizes around how we can actually deliver in healthcare, the standard of care. For example, there's a statistic from the early 2000s where we're seeing that it takes on average, about 17 years to translate research into practice. That takes a long time to get what we know works into the hospitals and the clinics and to the bedside."
"What's even worse is that not only does it take forever for that evidence to get to the frontline, but even when it does, what we're seeing is, on average, only about 14% of clinicians will actually adopt that innovation as standard of care. So that means over 80% of patients are getting that low-value care, potentially ineffective care. I think that's what shows up as poor outcomes for our patients."
#MultipleMyeloma #HealthEquity #PopulationHealth #SDOH #SocialDeterminantsofHealth #CancerCare
